1-3 of 3
Stephen D. Nimer, M.D.
Close
Sort by
Journal Articles

Clinical Activity of DNA Methyltransferase Inhibitors In Therapy-Related Myelodysplastic Syndromes: A Retrospective Study

Michael T Tees, M.D., Emily K. Dolezal, Stephen D. Nimer, M.D., Virginia M. Klimek, M.D.
Journal: Blood
Blood (2010) 116 (21): 1891.
https://doi.org/10.1182/blood.V116.21.1891.1891
Published: 2010
Journal Articles

Genetic Uncoupling of the Regulation of Hematopoietic Stem Cell Quiescence and Self-Renewal.

Yan Liu, PhD, Yasuhiko Miyata, Ph.D., Goro Sashida, Ph.D., Anthony Debalsio, MS, Yuhui Liu, Ph.D., Andrew Koff, Ph.D., Stephen D. Nimer, M.D.
Journal: Blood
Blood (2006) 108 (11): 1347.
https://doi.org/10.1182/blood.V108.11.1347.1347
Published: 2006
Journal Articles

Induction of Remission Prior to Transplantation Improves the Disease-Free Survival (DFS) of Patients with Advanced Myelodysplastic Syndromes (MDS) Treated with Myeloablative T - Cell Depleted (TCD) Stem Cell Transplants (SCT) from Histocompatible Unrelated Donors.

H.R. Castro-Malaspina, MD, Ann A. Jakubowski, M.D., Esperanza B. Papadopoulos, M.D., Farid Boulad, M.D., James W. Young, M.D., Nancy A. Kernan, M.D., Miguel-Angel Perales, M.D., Trudy N. Small, M.D., Michelle Chiu, Glenn Heller, Ph.D., Marcel Van Den Brink, M.D., Stephen D. Nimer, M.D., Richard J. O’Reilly, M.D.
Journal: Blood
Blood (2006) 108 (11): 4859.
https://doi.org/10.1182/blood.V108.11.4859.4859
Published: 2006